LaShanta Brice: PCOS Affects Millions, Yet Patient Voices Are Often Underrepresented in Scientific Spaces
LaShanta Brice, Scientific Engagement and Clinical Education Scientist at Stago, shared a post on LinkedIn:
“Excited to Speak Tomorrow at the Androgen Excess Society Annual Meeting!
I’m honored to represent both the scientific and patient communities as a PCOS Patient Advocate Scientist, sharing my journey and insights on how lived experience can inform and elevate clinical education and research.
Polycystic Ovary Syndrome (PCOS) affects millions, yet patient voices are often underrepresented in scientific spaces. I’m proud to help bridge that gap – bringing advocacy, education, and science together to drive meaningful change.
Grateful to PCOS Challenge and the Androgen Excess Society for the opportunity to contribute to this important dialogue. Let’s keep pushing for inclusive, patient-centered progress in endocrine health.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR